The Federal Government Just Split Cannabis into Two Legal Tracks Overnight — and Congress Could Kill Both Within Weeks

Last week, the Department of Justice, acting through DEA, created a dual-track federal cannabis regime: state-licensed medical cannabis moved to Schedule III, while recreational cannabis remains in Schedule I.¹ This bifurcation is unstable. A single appropriations rider could functionally nullify the entire framework before medical operators stabilize and before the broader rescheduling process advances.²

What Happened

On April 23, 2026, Acting Attorney General Todd Blanche issued a final order placing FDA-approved marijuana products and all marijuana subject to a qualifying state-issued medical license into Schedule III.³ The order took effect upon Federal Register publication on April 28.⁴ It rests on the Attorney General’s authority under 21 U.S.C. § 811(d)(1) to align domestic scheduling with U.S. obligations under the 1961 Single Convention on Narcotic Drugs.⁵

Simultaneously, the DEA opened its Medical Marijuana Dispensary Registration Portal on April 29.⁶ State-licensed medical operators may apply for expedited Schedule III registration at $794 per location.⁷ Applications filed by June 26 receive a guaranteed six-month processing window and may continue operations under their state licenses while pending.⁸ Trulieve Cannabis Corp. (TCNNF) filed first on April 29 for more than 200 dispensaries.⁹

Structural Consequences

Medical-track operators are now positioned to operate under Schedule III, subject to implementation and appropriations constraints. Section 280E of the Internal Revenue Code, which bars deductions and credits for businesses trafficking in Schedule I or II substances, should no longer apply to properly registered medical cannabis lines, subject to Treasury/IRS implementation rules.¹⁰ Treasury and IRS guidance confirms a transition rule treating the rescheduling as effective for the full taxable year that includes April 28—meaning calendar-year taxpayers receive 280E relief retroactive to January 1, 2026.¹¹ Forthcoming rules will require expense apportionment for mixed operators.¹²

Recreational operators remain Schedule I. They continue to face full 280E disallowance, federal banking restrictions, and potential enforcement exposure. Their fate hinges on a separate expedited administrative hearing before an administrative law judge that begins June 29 and must conclude by July 15.¹³

The bifurcated approach may not be accidental. By extending federal legitimacy only to state-licensed medical systems, regulators created a narrower reform that is easier to defend politically while isolating recreational markets for separate adjudication.

The May 13 Vote That Could Freeze Everything

On April 30 the House Appropriations Committee’s Commerce, Justice, Science Subcommittee advanced the FY 2027 CJS appropriations bill by an 8-6 party-line vote. Section 591 states: “None of the funds appropriated under this Act or otherwise made available by this Act may be used to reschedule marijuana … or to remove marijuana from the schedules established under section 202 of the Controlled Substances Act.”¹⁴ The full Committee marks up the bill May 13. Identical language advanced last year before being stripped in conference. This time the risk is material.¹⁵

GOP-Led Congressional Committee Votes To Block Marijuana Rescheduling, Defying Trump

If enacted or carried forward, Section 591 could freeze DEA implementation of the medical track, block further rescheduling actions, and create immediate legal uncertainty for newly registered operators—retroactively undermining the dual-track framework before it stabilizes.

Business Choices Now

Pure Medical Operators

• Deadline Risk: File by June 26 or lose expedited federal protection. Late filers face higher enforcement risk.¹⁶

• Compliance Imperative: Prepare Schedule III requirements immediately—security, biennial inventory, labeling, records, and disposal rules under 21 C.F.R. pts. 1301, 1308, 1317.¹⁷

• Tax Positioning: Update positions for full-year 2026 280E relief and model cash-flow gains; prepare for IRS apportionment scrutiny on any mixed activity.¹⁸

• Banking Opportunity: Engage partners now—Schedule III status materially improves payment processing and deposit options.¹⁹

Pure Recreational Operators

• Participation Decision: Decide on ALJ proceeding participation—electronic notices due by May 24.²⁰

• Political Imperative: Lobby aggressively against Section 591 before May 13 and for full rescheduling in the ALJ hearing. The narrower medical track may sap momentum for broader reform.

• Strategic Shift: Evaluate acquiring or expanding state medical licenses to move marginal capacity into the protected track.

• Financial Stress Test: Model 280E exposure through 2027 and optimize cash-tax planning, debt, and COGS.

Mixed Medical-Recreational Operators

• Allocation Uncertainty: Treasury has signaled forthcoming expense-allocation rules for overhead, rent, payroll, and other shared costs.²¹ Engage tax counsel immediately to model methods and build contemporaneous records.

• Structural Option: Consider separating medical and recreational lines into distinct entities to simplify compliance and reduce IRS disputes.

• Prioritization: Register medical dispensaries first where state law allows segregation.

• Suspension Watch: Monitor DEA triggers—state license issues automatically suspend federal registration.²²

Cross-Cutting Considerations

All operators should assess Single Convention compliance obligations (quotas, nominal-price government purchase/resale requirements).²³ Research opportunities expand under Schedule III. Banking improvements apply only to registered medical lines. Enforcement risk against non-registered medical activity remains live until the appropriations and ALJ processes conclude.

The May 13 markup is not ceremonial. Operators treating the current split as settled do so at their peril. Those who register promptly, model tax apportionment, participate in the ALJ process, and prepare contingencies will be best positioned—whatever the vote’s outcome.

Footnotes

¹ Schedules of Controlled Substances: Rescheduling of Food and Drug Administration Approved Products Containing Marijuana From Schedule I to Schedule III; Corresponding Change to Permit Requirements, 91 Fed. Reg. 22,714 (Apr. 28, 2026) (to be codified at 21 C.F.R. pts. 1300, 1301, 1308, 1312).

² H.R. ___ (CJS Appropriations Act, 2027), § 591 (subcomm. mark, Apr. 30, 2026).

³ U.S. Dep’t of Justice, Press Release, Justice Department Places FDA-Approved Marijuana Products and Products Containing Marijuana Subject to a Qualifying State-issued License in Schedule III (Apr. 23, 2026).

⁴ 91 Fed. Reg. at 22,715.

⁵ 21 U.S.C. § 811(d)(1) (2022); Single Convention on Narcotic Drugs, Mar. 30, 1961, 18 U.S.T. 1407, 520 U.N.T.S. 151.

⁶ U.S. Drug Enforcement Admin., Medical Marijuana Registration Portal Notice; see also Nate Raymond, U.S. DEA Medical Marijuana Registration Portal to Launch Wednesday, Reuters (Apr. 27, 2026).

⁷ 21 C.F.R. § 1301.13(k) (as amended).

⁸ 91 Fed. Reg. at 22,720.

⁹ Trulieve Cannabis Corp., Press Release, Trulieve Announces Applications Filed for DEA Registration of State Licensed Medical Marijuana Businesses (Apr. 29, 2026).

¹⁰ I.R.C. § 280E.

¹¹ U.S. Dep’t of the Treasury, Press Release SB0471, Treasury, IRS Announce Process for Tax Guidance Following DOJ Final Order on Medical Marijuana Rescheduling (Apr. 23, 2026) (transition rule).

¹² Id. (apportionment guidance).

¹³ 91 Fed. Reg. 22,777 (Apr. 28, 2026) (notice of hearing).

¹⁴ H.R. ___ (CJS Appropriations Act, 2027), § 591 (subcomm. mark, Apr. 30, 2026).

¹⁵ Id.

¹⁶ 21 C.F.R. § 1301.13(k)(2).

¹⁷ 21 C.F.R. pts. 1301, 1308, 1317.

¹⁸ Treasury Press Release SB0471, supra note 11.

¹⁹ Id.

²⁰ 91 Fed. Reg. 22,777 (May 24 electronic deadline).

²¹ Treasury Press Release SB0471, supra note 11.

²² 21 C.F.R. § 1301.76.

²³ Single Convention on Narcotic Drugs, supra note 5, Arts. 23, 28; 91 Fed. Reg. at 22,719.